Eur Rev Med Pharmacol Sci 2020; 24 (12): 7051-7057

DOI: 10.26355/eurrev_202006_21698

Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report

V. Granata, R. Palaia, V. Albino, M. Piccirillo, S. Venanzio Setola, A. Petrillo, F. Izzo

Division of Radiology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy. v.granata@istitutotumori.na.it


OBJECTIVE: Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy after hepatocellular carcinoma. The current standard palliative treatment, chemotherapy regimen with gemcitabine and cisplatin, prolongs overall survival only of a few months. Established locoregional therapies are not a curative option or an alternative to surgery in the treatment of CCA. We report a case of a patient affected by a cholangiocellular carcinoma at hepatic hilum treated by Electrochemotherapy (ECT) at our oncologic center.

CASE PRESENTATION: A 71 years old male affected by a CCA at hepatic hilum was treated with ECT according to ESOPE guidelines. No complications occurred during ECT procedure. The patient was discharged after 10 days. The functional MR evaluation at 2 and at 4 months post-treatment showed a significant response without significant post-treatment adverse events. The Computed tomography (CT) assessment after 18 months did not show progression of disease.

CONCLUSIONS: ECT is safe and its use could be suggested as a palliative treatment of advanced neoplastic lesions in which radical surgical treatment is not possible.

Free PDF Download

To cite this article

V. Granata, R. Palaia, V. Albino, M. Piccirillo, S. Venanzio Setola, A. Petrillo, F. Izzo
Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a case report

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 12
Pages: 7051-7057
DOI: 10.26355/eurrev_202006_21698